Intrathecal Drug Delivery for Pain and Spasticity

Dr. Diwan is a world renown luminary in Minimally Invasive Spine Methods. A former fellowship director, at Cornell University, Dr. Diwan now leads the Latin American Pain Society and the New York New Jersey Pain Symposium, one of the premier meetings in the space. In addition, he has authored hundreds of articles, chapters and books. Dr. Deer and Dr. Diwan frequently teach these methods of Minimally Invasive Spine surgery around the world and have an extensive network of physicians who are renowned in all areas of the book. Timothy R. Deer is a clinical professor of anesthesiology at the West Virginia University School of Medicine, where he also received his medical degree. He completed his training in anesthesiology and pain medicine at the University of Virginia. Dr. Deer has published on a range of topics, including injection techniques, minimally invasive disc procedures, intrathecal drug delivery, and spinal cord and peripheral nerve stimulation. He lectures at many national and international symposiums and has been involved in the hands-on training of more than a thousand interventional pain specialists. He serves on the board of directors of the North American Neuromodulation Society and American Academy of Pain Medicine. He is a past chair of the committee on pain medicine of the American Society of Anesthesiologists, a member of the editorial board of the journal Neuromodulation, president of the West Virginia Society of Interventional Pain Physicians, and serves on several other boards and committees.

• SECTION I: General ConsiderationsChapter 1: Basic Science of Spinal ReceptorsChapter 2: Pharmacologic Agents and Compounding of Intrathecal DrugsChapter 3: Polyanalgesia for Implantable Drug Delivery SystemsChapter 4: Principles of Patient Management for Intrathecal AnalgesiaChapter 5: Patient Selection for Intrathecal Infusion to Treat Chronic PainChapter 6: Patient PreparationChapter 7: Psychological Considerations in IDD Chapter 8: Intrathecal Drug Delivery: Medical Necessity, Documentation, Coding and BillingSECTION II: Implant DevicesChapter 9: Methods of Trials for Consideration of ITDDSChapter 10: Techniques of Implant Placement for Intrathecal PumpsChapter 11: Programmable versus Fixed-Rate Pumps for Intrathecal Drug Delivery Chapter 12: SynchroMed EL vs SynchroMed IIChapter 13: Minimizing the Risks of Intrathecal TherapyChapter 14: Complications Associated with Intrathecal Drug Delivery SystemsSECTION III: Evidence-based practiceChapter 15: Management of ITDDS in Patients with Co-MorbiditiesChapter 16: Cost-Effectiveness of Implanted Drug Delivery SystemsChapter 17: Neuroaugmentation by Stimulation vs. Intrathecal Drug Delivery SystemsChapter 18: Anticoagulation guidelines and Intrathecal Drug Delivery SystemsChapter 19: Intrathecal Therapy for Malignant PainSECTION IV: ITDDs for spasticityChapter 20: Intrathecal Baclofen TrialingChapter 21: Baclofen Pump Management SECTION V: Future of ITDDsChapter 22: Future of Intrathecal Drug Delivery Systems (including new devices)Chapter 23: Trialing for Ziconotide Intrathecal Analgesic TherapyChapter 24: Perioperative Management of Patients with ITDDS